Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy

Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy

Background & Aims. Interpretation of key aspects of pathogenesis of chronic myeloid leukemia (CML) and development and introduction of target therapy have changed the prognosis of this once fatal disease dramatically. Results of numerous clinical trials demonstrated substantial superiority of ty...

Full description

Bibliographic Details
Main Authors: KM Abdulkadyrov, VA Shuvaev, IS Martynkevich, MS Fominykh, NA Potikhonova, II Zotova, VYu Udal’eva, RA Golovchenko, NV Shakhvorostova, DI Shikhbabaeva, MN Zenina, SA Tiranova, SA Kudryashova, LS Martynenko, MP Ivanova, NYu Tsybakova, EV Petrova, LB Polushkina, EV Kleina
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2016-01-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
chronic myeloid leukemia
target therapy
tyrosine kinase inhibitors
imatinib
nilotinib
dasatinib
clinical practice
Online Access:http://bloodjournal.ru/en/chronic-myeloid-leukemia-long-term-experience-of-target-therapy/

Internet

http://bloodjournal.ru/en/chronic-myeloid-leukemia-long-term-experience-of-target-therapy/

Similar Items